Novartis AG (NVS)
97.19
-0.08
(-0.08%)
USD |
NYSE |
May 06, 12:04
Novartis Amortization Expense CF (Quarterly)
Amortization Expense CF (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Amortization Expense CF (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -- |
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
Date | Value |
---|---|
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
March 31, 2019 | -- |
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
Amortization Definition
Amortization is the calculated distribution of liability payments over a period of years. Payments cover principle and interest. Amortization schedules are frequently used to calculate mortgage payments. Can also refer to the gradual value depreciation of a tangible asset.
Amortization Expense CF (Quarterly) Range, Past 5 Years
Amortization Expense CF (Quarterly) Benchmarks
Roche Holding AG | -- |
Sandoz Group AG | -- |
Amgen Inc | -- |
Incyte Corp | -- |
MorphoSys AG | -- |